News
A new study shows young adults with higher exposure to atherogenic lipoprotein particles may be at a greater risk of ...
XyloCor Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapies for cardiovascular disease, announced the first patient has been dosed in the Phase 2b EXACT-2 ...
Dr Amal Muthumala, consultant cardiologist at North Middlesex University Hospital and Barts Heart Centre, in London, has ...
A new study released in JAMA finds life expectancy has still not bounced back from pre-pandemic 2019 levels, attributing the ...
Nearly 1 in 3 American adolescents have prediabetes, a CDC report finds. An official notes "it’s not too late to change ...
The Association of Black Cardiologists (ABC), a national 501c3 nonprofit focused on advancing cardiovascular wellness for all ...
During the menopause transition, only 1 in 5 women have optimal scores using the American Heart Association's ...
Suddenly feeling old? Evidence now suggests that rather than a long, steady decline, we dramatically age around three ...
SGLT2 inhibitor use may help stabilize eGFR levels for patients with autosomal dominant polycystic kidney disease and type 2 diabetes, according to study data.“Given its unique pathophysiology, ...
A new study found that semaglutides like Ozempic are linked to a lower risk of Alzheimer's disease and dementia. Below, a ...
The Healthy.io, Geisinger and Boehringer Ingelheim partnership showed a 2.5x increase in test completion rates than standard clinical care.
Irregular sleep, including later sleep timing and poor continuity, was associated with increased risk for metabolic syndrome among Black adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results